Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Everest Group, Ltd. $EG Stock Holdings Lowered by Bank of New York Mellon Corp
Everest Group (EG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
California Public Employees Retirement System Lowers Stock Holdings in Everest Group, Ltd. $EG
Everest Group Designates TP as a Leader in Healthcare CXM as AI Redefines Customer Experience
EG Outperforms Industry, Trades Near 52-Week High: Time to Exit?
Claritev Rises to Leader Ranking in Everest Group's 2026 Pre-Payment Integrity Solutions PEAK Matrix® Assessment
Is It Too Late to Buy Everest Group Ltd (EG) After 3.2% Rally? GF Value Says Undervalued
Everest Group: Generating An 11% Yield On A Large Notional Long Position
Everest Group to Hold Second Quarter 2026 Earnings Conference Call on Thursday, July 30, 2026
Everest Group's Net Investment Income Powers Earnings Growth
Magnit Global™ Recognized as a Global Leader in Everest Group's 2026 VMS PEAK Matrix® Assessment
Everest and Stone Point Announce the Launch of Casualty Sidecar Annapurna Re Ltd; Stone Point Serves as Anchor Investor in Multi-Year Vehicle
EG Stock Trades Near 52-Week High: Should Investors Exit or Hold?
Travere licenses Everest's kidney disease drug in deal worth up to $1.14 billion
Travere Therapeutics Enters Into Exclusive Licensing Agreement with Everest Medicines for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases
Everest Group (EG) Down 6.6% Since Last Earnings Report: Can It Rebound?
Simform Recognized in Everest Group's Software Product Engineering Services PEAK Matrix® Assessment 2026
Everest Establishes Joseph V. Taranto Scholarship to Advance Commitment to Developing Future Leaders
Everest Establishes Joseph V. Taranto Scholarship to Advance Commitment to Developing Future Leaders
AIG to Acquire Everest Colombia Unit, Expand Latin America Footprint